Refine
Has Fulltext
- yes (61)
Is part of the Bibliography
- yes (61) (remove)
Year of publication
Document Type
- Journal article (61)
Keywords
- osteoarthritis (5)
- knee (4)
- MSCs (3)
- total hip arthroplasty (3)
- total knee arthroplasty (3)
- tranexamic acid (3)
- vitamin D (3)
- AMADEUS (2)
- COVID-19 (2)
- Germany (2)
- Medizin (2)
- TKA (2)
- cartilage (2)
- cartilage regeneration (2)
- chondrocytes (2)
- direct anterior approach (2)
- implant positioning (2)
- knee arthroplasty (2)
- knee osteoarthritis (2)
- knee replacement (2)
- mechanotransduction (2)
- mesenchymal stromal cells (2)
- patient-specific (2)
- periprosthetic infection (2)
- periprosthetic joint infection (2)
- prospective study (2)
- revision arthroplasty (2)
- scaffolds (2)
- spacer (2)
- stem cells (2)
- tissue engineering (2)
- total joint arthroplasty (2)
- two-stage exchange (2)
- 3D models (1)
- 3D organoids (1)
- Anatomic reattachment (1)
- Aseptic loosening (1)
- Bone marrow (1)
- Bone tumor (1)
- CYP24A1 (1)
- Cartilage regeneration (1)
- Case report (1)
- Chondrosarcoma (1)
- Copal\(^®\) spacem (1)
- Desmoplastic fibroma (1)
- Distal biceps tendon repair (1)
- Fraktur (1)
- Glenohumeralgelenk (1)
- Hip joint (1)
- Hueter interval (1)
- ICRS (1)
- Joint capsule (1)
- KOOS (1)
- Ligamentum capitis femoris (1)
- MPFL (1)
- MRI (1)
- Non-simultaneous bilateral distal biceps tendon rupture (1)
- Osteoarthritis (1)
- Osteoporose (1)
- Osteosynthese (1)
- PMMA (1)
- PMMA bone cement (1)
- PROM (1)
- Paprosky (1)
- Schulterendoprothetik (1)
- Soft-tissue sarcoma (1)
- Staphylococcus aureus / drug effects (1)
- Suture anchor (1)
- Synovial Fluid Aspiration (1)
- Tissue engineering (1)
- Total knee arthroplasty (1)
- VDR (1)
- Vancomycin / administration & dosage (1)
- Vancomycin / chemistry (1)
- Vancomycin / pharmacology (1)
- acetabular bone defect (1)
- age and gender analysis (1)
- age distribution (1)
- algorithm (1)
- anatomic center of rotation (1)
- anatomical landmark (1)
- anterior approach (1)
- anti-bacterial agents / administration & dosage (1)
- anti-bacterial agents / chemistry (1)
- anti-bacterial agents / pharmacology (1)
- antibiotic elution (1)
- apoptosis (1)
- approach (1)
- aseptic loosening (1)
- asymmetric implant (1)
- autograft (1)
- autologous chondrocyte implantation (1)
- autophagy (1)
- axial alignment (1)
- benige tumor (1)
- benign bone tumor (1)
- bi-compartmental (1)
- bi-compartmental knee arthoplasty (1)
- biocompatible Materials (1)
- bone (1)
- bone cement (1)
- bone marrow edema (1)
- bone metastasis (1)
- bone model (1)
- bone tissue engineering (1)
- bone tumour (1)
- bone wires (1)
- calcification (1)
- cartilage defect (1)
- cartilage defects (1)
- cartilage surgery (1)
- case report (1)
- cell-based therapies (1)
- cell-matrix interaction (1)
- cellular origin (1)
- chondral defect (1)
- chondrogenic differentiation (1)
- click chemistry (1)
- clinical outcome (1)
- colony-stimulating factor (1)
- compressive load (1)
- compressive strength (1)
- computer navigation (1)
- consensus (1)
- core depression (1)
- correlation (1)
- curettage (1)
- custom made implant (1)
- custom-made implant (1)
- decellularization (1)
- defects (1)
- dermal fibroblasts (1)
- dexamethasone (1)
- differentiation capacity (1)
- drain (1)
- drug liberation (1)
- elution (1)
- epidemiological analysis (1)
- extracellular vesicles (1)
- fast track rehabilitation (1)
- fast-track-concepts (1)
- fibrin (1)
- fluid simulation (1)
- foot and ankle procedures (1)
- fracture incidence (1)
- fragility fractures (1)
- gentamicin-loaded poly (methyl methacrylate) bone cement (1)
- germanophone (1)
- glycocalyx (1)
- grading system of chondral defects (1)
- hMSC-TERT (1)
- hMSCs (1)
- haemoglobin (1)
- handball (1)
- hematoma (1)
- high tibial osteotomy (1)
- high tibial valgus osteotomy (1)
- hip (1)
- hip joint (1)
- hip replacement (1)
- human trabecular bone decellularization (1)
- hydrogels (1)
- hypovitaminosis D (1)
- iTotal (1)
- immunomodulation (1)
- immunotherapy (1)
- implant fit (1)
- in situ guided tissue regeneration (1)
- in vitro (1)
- in vitro modeling (1)
- inbound medical tourism (1)
- inpatient rehabilitation (1)
- interstage aspiration (1)
- joint aspiration (1)
- knee alignment (1)
- knee axis (1)
- knee joint (1)
- knee rotator cuff (1)
- level of evidence III (1)
- linear regression (1)
- lower extremity (1)
- lower extremity amputation (1)
- major amputation (1)
- malignancy (1)
- materials testing (1)
- mayo stem (1)
- mechanical alignment (1)
- mechanosensing (1)
- medial patellofemoral ligament (1)
- medical collateral ligament (1)
- mesenchymal cells (1)
- mesenchymal tissues (1)
- metabolic glycoengineering (1)
- metabolism (1)
- microbiological culture (1)
- minimal invasive surgery (1)
- minimally invasive (1)
- minimally invasive surgery (1)
- minimally-invasive (1)
- minor amputation (1)
- modified monosaccharides (1)
- multicomponent stretching (1)
- muscle (1)
- musculoskeletal sarcoma (1)
- myokines (1)
- open surgical repair (1)
- orthopaedic surgery (1)
- orthopaedics (1)
- orthopedic surgery (1)
- osteochondral allografts (1)
- osteogenesis (1)
- osteogenesis imperfecta (1)
- osteokines adaptation (1)
- pandemic (1)
- patella alta (1)
- patella dislocation (1)
- patella instability (1)
- patient blood management (1)
- patient reported outcome measures (1)
- patient specific implant (1)
- patient-specific knee arthroplasty (1)
- pelvic discontinuity (1)
- perforator (1)
- perioperative management (1)
- personalised orthopaedic implantation (1)
- phenotype (1)
- platelet-rich plasma (1)
- polymethylmethacrylate (1)
- posterior tibial slope (1)
- postoperative Komplikationen (1)
- postoperative rehabilitation (1)
- pre- and post-outbreak comparison (1)
- progenitor cells (1)
- prostheses and implants (1)
- rare bone tumor (1)
- regenerative capacity (1)
- regenerative medicine (1)
- regenerative therapies (1)
- regional transient osteoporosis (1)
- repair (1)
- revision hip (1)
- robotic (1)
- scaffold-free (1)
- scientific publications (1)
- scoping review (1)
- segmental collapse (1)
- senescence (1)
- senescence‐associated secretory phenotype (1)
- septic (1)
- shear stress (1)
- sheep model (1)
- short hip stem (1)
- shoulder injuries (1)
- stem cell niche (1)
- stemness (1)
- stimulation (1)
- stromal cells (1)
- sutures (1)
- tendon tissue engineering (1)
- tenogenic differentiation (1)
- therapy (1)
- total knee replacement (1)
- toxicity (1)
- transgluteal approach (1)
- translational research (1)
- transplantation (1)
- triangle method (1)
- tricompartmental knee osteoarthritis (1)
- trochlear dysplasia (1)
- tumour malignancy (1)
- vitamin C (1)
- vitamin D deficiency (1)
- vitamin D receptor (1)
- weight bearing line (1)
- white blood cell count (1)
Institute
- Lehrstuhl für Orthopädie (61) (remove)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 101034412 (1)
- 241719 (1)
- 242175 (1)
- 810850 (1)
- EU-1650-0006 (1)
Introduction: To date, no single most-appropriate factor or delivery method has been identified for the purpose of mesenchymal stem cell (MSC)-based treatment of cartilage injury. Therefore, in this study we tested whether gene delivery of the growth factor Indian hedgehog (IHH) was able to induce chondrogenesis in human primary MSCs, and whether it was possible by such an approach to modulate the appearance of chondrogenic hypertrophy in pellet cultures in vitro. Methods: First-generation adenoviral vectors encoding the cDNA of the human IHH gene were created by cre-lox recombination and used alone or in combination with adenoviral vectors, bone morphogenetic protein-2 (Ad.BMP- 2), or transforming growth factor beta-1 (Ad.TGF-b1) to transduce human bone-marrow derived MSCs at 5 × 102 infectious particles/cell. Thereafter, 3 × 105 cells were seeded into aggregates and cultured for 3 weeks in serumfree medium, with untransduced or marker gene transduced cultures as controls. Transgene expressions were determined by ELISA, and aggregates were analysed histologically, immunohistochemically, biochemically and by RT-PCR for chondrogenesis and hypertrophy. Results: IHH, TGF-b1 and BMP-2 genes were equipotent inducers of chondrogenesis in primary MSCs, as evidenced by strong staining for proteoglycans, collagen type II, increased levels of glycosaminoglycan synthesis, and expression of mRNAs associated with chondrogenesis. IHH-modified aggregates, alone or in combination, also showed a tendency to progress towards hypertrophy, as judged by the expression of alkaline phosphatase and stainings for collagen type X and Annexin 5. Conclusion: As this study provides evidence for chondrogenic induction of MSC aggregates in vitro via IHH gene delivery, this technology may be efficiently employed for generating cartilaginous repair tissues in vivo.